{"id":27573,"date":"2024-01-03T21:48:44","date_gmt":"2024-01-03T19:48:44","guid":{"rendered":"https:\/\/hho-bulgaria.com\/hydrogen-rich-saline-shields-mice-from-agvhd\/"},"modified":"2024-02-04T21:12:19","modified_gmt":"2024-02-04T19:12:19","slug":"hydrogen-rich-saline-shields-mice-from-agvhd","status":"publish","type":"post","link":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/","title":{"rendered":"Hydrogen-Rich Saline Shields Mice from aGVHD"},"content":{"rendered":"<section id=&quot;ArticleBody&quot;>\n<p id=&quot;O3-3-2&quot;>Allogeneic hematopoietic stem cell transplantation (HSCT) has been widely used for the treatment of hematologic malignant and nonmalignant hematologic diseases, although it is restricted by its severe complications (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R1-3 R2-3&quot;>1, 2<\/a><\/sup>). One major complication associated with HSCT is acute graft-versus-host disease (aGVHD), which is always a major cause of death after allo-HSCT (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R3-3&quot;>3<\/a><\/sup>). The pathophysiology of aGVHD involves complex three stages. Stage I involves tissue damage and cellular activation induced by preconditioning. Stage II involves the activation of donor lymphocytes (T cells), followed by a third stage, in which cellular and inflammatory factors are released, including tumor necrosis factor (TNF)-\u03b1, interleukin (IL)-1, and IL-6. These cytotoxic molecules directly attack various host tissues and underlie the clinical manifestations of aGVHD (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R4-3 R5-3&quot;>4, 5<\/a><\/sup>). The activated cells also produce a large number of harmful free radicals resulting in severe cell damage (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R3-3&quot;>3<\/a><\/sup>).<\/p>\n<p id=&quot;O3-3-3&quot;>Hydrogen has been extensively used in chemical fields, such as fuel processing and fertilizer production (3H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub>+N<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub>\u21922NH<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>3<\/sub>). It was considered to be the physiologic inert gas, which is rarely used in the medical field. However, in 2007, Ohsawa et al. (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R6-3&quot;>6<\/a><\/sup>) discovered that H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> gas has antioxidant and antiapoptotic properties that protect the brain against ischemia\u2013reperfusion injury and stroke by selectively neutralizing hydroxyl and peroxynitrite radicals. Since then, H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> gas has come to the forefront of therapeutic medical gas research. We also have proposed and proven that hydrogen has radioprotective effects in cultured cells and mice (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R7-3 R8-3 R9-3 R10-3&quot;>7\u201310<\/a><\/sup>).<\/p>\n<p id=&quot;O3-3-4&quot;>Recent basic and clinical research has revealed that hydrogen is an important physiologic regulatory factor with anti-inflammatory, antioxidant, and antiapoptotic protective effects on cells and organs, proving that hydrogen could down-regulate cytokines, such as CCL2, IL-1\u03b2, IL-6, IL-12, and TNF-\u03b1 (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R11-3 R12-3 R13-3 R14-3 R15-3&quot;>11\u201315<\/a><\/sup>), which play important roles on the development of aGVHD. Also, free radicals exert an important role in the occurrence and development of aGVHD (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R16-3 R17-3&quot;>16, 17<\/a><\/sup>). Therefore, we reasoned that hydrogen might have therapeutic effects on aGVHD. However, the application of H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> gas inhalation is not convenient and may be dangerous because it is inflammable and explosive. As we reported previously, H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> gas saturated saline, which is called hydrogen-rich saline, is easy to apply and is safe (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R7-3&quot;>7<\/a><\/sup>). In the current study, we investigated whether the administration of hydrogen-rich saline exerted a therapeutic effect on aGVHD mice. We demonstrated here that hydrogen treatment could protect mice from lethal GVHD and increase the clinical score of aGVHD mice and also could promote the recovery of white blood cells of aGVHD mice.<\/p>\n<h2 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;1&quot; id=&quot;O8-3&quot;>RESULTS<\/h2>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O4-3&quot;>Hydrogen Administration After Bone Marrow Transplantation Protects Mice From Lethal Graft-Versus-Host Disease<\/h3>\n<p id=&quot;O4-3-2&quot;>Initial studies were performed to determine whether hydrogen could protect mice from lethal GVHD in a major histocompatibility complex\u2013incompatible murine bone marrow transplantation (BMT) model. Mice were treated intraperitoneally with physiologic saline or hydrogen-rich saline (5 mL\/kg) 24 hr after transplantation every day. Forty percent of GVHD mice without H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> treatment died by the 16th day after BMT (<a href=&quot;javascript:void(0)&quot; onclick=&quot;javascript:showSlideShowByImageID('F1-3', '00007890-201303150-00003');&quot;>Fig. 1<\/a>), whereas 80% of the mice pretreated with H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> had survived (<a href=&quot;javascript:void(0)&quot; onclick=&quot;javascript:showSlideShowByImageID('F1-3', '00007890-201303150-00003');&quot;>Fig. 1<\/a>). Thus, H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> could protect mice from lethal GVHD.<\/p>\n<section class=&quot;ejp-r-article-images&quot;>\n<figure class=&quot;ejp-r-article-images__figure&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__image-link&quot; onclick=&quot;showSlideShowByImageID('F1-3', '00007890-201303150-00003')&quot;><img class=&quot;ejp-r-article-images__img js-lazy-load lazy-load&quot; src=&quot;javascript:void(0);&quot; data-src=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview.00007890-201303150-00003.F1-3.jpeg&quot; data-srcset=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview@2.00007890-201303150-00003.F1-3.jpeg 2x&quot; srcset=&quot;&quot; alt=&quot;F1-3&quot;><\/a><figcaption class=&quot;ejp-r-article-images__figcaption&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__figcaption-link&quot; onclick=&quot;showSlideShowByImageID('F1-3', '00007890-201303150-00003')&quot;>FIGURE 1: <\/a><\/p>\n<div class=&quot;ejp-r-article-images__figcaption-text&quot;>Administration of hydrogen-rich saline after transplantation protects mice from lethal GVHD (n=20, three repeats; <em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>P<\/em>&lt;0.05). GVHD, graft-versus-host disease.<\/div>\n<\/figcaption><\/figure>\n<\/section>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O5-3&quot;>Hydrogen Reduces Serum Cytokine Levels in Mice Undergoing Graft-Versus-Host Disease<\/h3>\n<p id=&quot;O5-3-2&quot;>We examined the serum cytokine levels to determine whether hydrogen affected cytokine levels that were increased during the course of GVHD. Mice in all groups were bled on day 7 after BMT and analyzed for the specified cytokines. Untreated mice with GVHD had increased levels of TNF-\u03b1, IL-2, and IL-10 compared with control animals (<em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>P<\/em>&lt;0.01 for all three cytokines; <a href=&quot;javascript:void(0)&quot; onclick=&quot;javascript:showSlideShowByImageID('F2-3', '00007890-201303150-00003');&quot;>Fig. 2<\/a>). The administration of hydrogen resulted in a significant decrease in serum levels of all three cytokines (<a href=&quot;javascript:void(0)&quot; onclick=&quot;javascript:showSlideShowByImageID('F2-3', '00007890-201303150-00003');&quot;>Fig. 2<\/a>) compared with untreated mice with GVHD (<em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>P<\/em>&lt;0.05 for all three cytokines).<\/p>\n<section class=&quot;ejp-r-article-images&quot;>\n<figure class=&quot;ejp-r-article-images__figure&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__image-link&quot; onclick=&quot;showSlideShowByImageID('F2-3', '00007890-201303150-00003')&quot;><img class=&quot;ejp-r-article-images__img js-lazy-load lazy-load&quot; src=&quot;javascript:void(0);&quot; data-src=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview.00007890-201303150-00003.F2-3.jpeg&quot; data-srcset=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview@2.00007890-201303150-00003.F2-3.jpeg 2x&quot; srcset=&quot;&quot; alt=&quot;F2-3&quot;><\/a><figcaption class=&quot;ejp-r-article-images__figcaption&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__figcaption-link&quot; onclick=&quot;showSlideShowByImageID('F2-3', '00007890-201303150-00003')&quot;>FIGURE 2: <\/a><\/p>\n<div class=&quot;ejp-r-article-images__figcaption-text&quot;>Hydrogen effectively reduces serum cytokine levels in mice with GVHD (n=12, three repeats; <em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>P<\/em>&lt;0.01). GVHD, graft-versus-host disease.<\/div>\n<\/figcaption><\/figure>\n<\/section>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O6-3&quot;>Hydrogen Improves Clinic Symptoms of Graft-Versus-Host Disease Mice<\/h3>\n<p id=&quot;O6-3-2&quot;>To determine the therapeutic effects of hydrogen, the clinical signs of GVHD on the 15th day after BMT were scored on the criteria provided in <a href=&quot;javascript:void(0)&quot; onclick=&quot;javascript:showSlideShowByImageID('T1-3', '00007890-201303150-00003');&quot;>Table 1<\/a>. As shown in <a href=&quot;javascript:void(0)&quot; onclick=&quot;javascript:showSlideShowByImageID('F3-3', '00007890-201303150-00003');&quot;>Figure 3<\/a>, hydrogen significantly improved clinic symptoms of GVHD mice (<em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>P<\/em>&lt;0.01). Also in <a href=&quot;javascript:void(0)&quot; onclick=&quot;javascript:showSlideShowByImageID('F3-3', '00007890-201303150-00003');&quot;>Figure 3<\/a>, the weight of GVHD mice treated with hydrogen was significantly higher than that of GVHD mice treated with hydrogen (<em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>P<\/em>&lt;0.05).<\/p>\n<section class=&quot;ejp-r-article-images&quot;>\n<figure class=&quot;ejp-r-article-images__figure&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__image-link&quot; onclick=&quot;showSlideShowByImageID('T1-3', '00007890-201303150-00003')&quot;><img class=&quot;ejp-r-article-images__img js-lazy-load lazy-load&quot; src=&quot;javascript:void(0);&quot; data-src=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview.00007890-201303150-00003.T1-3.jpeg&quot; data-srcset=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview@2.00007890-201303150-00003.T1-3.jpeg 2x&quot; srcset=&quot;&quot; alt=&quot;T1-3&quot;><\/a><figcaption class=&quot;ejp-r-article-images__figcaption&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__figcaption-link&quot; onclick=&quot;showSlideShowByImageID('T1-3', '00007890-201303150-00003')&quot;>TABLE 1: <\/a><\/p>\n<div class=&quot;ejp-r-article-images__figcaption-text&quot;>Clinical scoring criteria of GVHD mice<\/div>\n<\/figcaption><\/figure>\n<figure class=&quot;ejp-r-article-images__figure&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__image-link&quot; onclick=&quot;showSlideShowByImageID('F3-3', '00007890-201303150-00003')&quot;><img class=&quot;ejp-r-article-images__img js-lazy-load lazy-load&quot; src=&quot;javascript:void(0);&quot; data-src=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview.00007890-201303150-00003.F3-3.jpeg&quot; data-srcset=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview@2.00007890-201303150-00003.F3-3.jpeg 2x&quot; srcset=&quot;&quot; alt=&quot;F3-3&quot;><\/a><figcaption class=&quot;ejp-r-article-images__figcaption&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__figcaption-link&quot; onclick=&quot;showSlideShowByImageID('F3-3', '00007890-201303150-00003')&quot;>FIGURE 3: <\/a><\/p>\n<div class=&quot;ejp-r-article-images__figcaption-text&quot;>Administration of hydrogen-rich saline after transplantation increases the clinical score of aGVHD mice (n=12, three repeats; <em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>P<\/em>&lt;0.01). aGVHD, acute graft-versus-host disease.<\/div>\n<\/figcaption><\/figure>\n<\/section>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O7-3&quot;>Hydrogen Promotes the Recovery of Peripheral Blood Leukocytes<\/h3>\n<p id=&quot;O7-3-2&quot;>Leukocyte counts declined rapidly and elevated gradually from day 9 after BMT. Within the whole post-BMT period, the recovery of leukocytes in the H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> groups was significantly faster than that of the non-H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> groups (<a href=&quot;javascript:void(0)&quot; onclick=&quot;javascript:showSlideShowByImageID('F4-3', '00007890-201303150-00003');&quot;>Fig. 4<\/a>).<\/p>\n<section class=&quot;ejp-r-article-images&quot;>\n<figure class=&quot;ejp-r-article-images__figure&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__image-link&quot; onclick=&quot;showSlideShowByImageID('F4-3', '00007890-201303150-00003')&quot;><img class=&quot;ejp-r-article-images__img js-lazy-load lazy-load&quot; src=&quot;javascript:void(0);&quot; data-src=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview.00007890-201303150-00003.F4-3.jpeg&quot; data-srcset=&quot;https:\/\/images.journals.lww.com\/transplantjournal\/ArticleViewerPreview@2.00007890-201303150-00003.F4-3.jpeg 2x&quot; srcset=&quot;&quot; alt=&quot;F4-3&quot;><\/a><figcaption class=&quot;ejp-r-article-images__figcaption&quot;><a href=&quot;javascript:void(0)&quot; class=&quot;ejp-r-article-images__figcaption-link&quot; onclick=&quot;showSlideShowByImageID('F4-3', '00007890-201303150-00003')&quot;>FIGURE 4: <\/a><\/p>\n<div class=&quot;ejp-r-article-images__figcaption-text&quot;>Administration of hydrogen-rich saline after transplantation promotes the recovery of white blood cells of aGVHD mice (n=12, three repeats; <em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>P<\/em>&lt;0.05). aGVHD, acute graft-versus-host disease.<\/div>\n<\/figcaption><\/figure>\n<\/section>\n<p id=&quot;O7-3-4&quot;>On day 28 after BMT, leukocyte counts in the H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> group returned to 7.8\u00d710<sup xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>9<\/sup>\/L compared with 4.75\u00d710<sup xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>9<\/sup>\/L in the non-H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> group.<\/p>\n<h2 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;1&quot; id=&quot;O9-3&quot;>DISCUSSION<\/h2>\n<p id=&quot;O9-3-2&quot;>To our knowledge, hydrogen was firstly applied on hematologic diseases. Also, this is the first study demonstrating that hydrogen has therapeutic effect on aGVHD mice.<\/p>\n<p id=&quot;O9-3-3&quot;>Nowadays, the standard initial therapy for GVHD includes the use of high-dose steroids, which results in approximately 40% complete response (CR) rate (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R18-3&quot;>18<\/a><\/sup>). This CR rate is unsatisfactory, and in patients who have less than a CR, there is high mortality both from the GVHD itself and from the steroid-related infectious complications. The treatment of steroid-resistant aGVHD is very difficult, and many institutions use monoclonal antibody (mAb), such as anti-TNF-\u03b1 mAb, anti-CD52 mAb, anti-CDl47 mAb (ABX.CBL), and anti-CD3 mAb to treat steroid-resistant aGVHD patients, but their therapeutic effects are not ideal although with high infection rate. Overall, those treatments of aGVHD did not achieve significant breakthroughs.<\/p>\n<p id=&quot;O9-3-4&quot;>In our study, we demonstrated here that hydrogen treatment could protect mice from lethal GVHD and improve clinic syndrome of aGVHD mice and also could promote the recovery of white blood cells of aGVHD mice. Its mechanisms may involve, in part or exclusively, reducing the levels of TNF-\u03b1, which is a major cytokine mediator of GVHD-induced tissue damage (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R19-3 R20-3 R21-3&quot;>19\u201321<\/a><\/sup>). IL-2 was also reduced in aGVHD mice treated with hydrogen, which also play an important role in the development of aGVHD. Besides, this therapeutic effect may result from the reactive oxygen species scavenging effect of molecular H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R6-3&quot;>6<\/a><\/sup>), because free radicals exert an important role in the occurrence and development of aGVHD (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R16-3 R17-3&quot;>16, 17<\/a><\/sup>). A few side effects of hydrogen were reported. Hydrogen is continuously produced by colonic bacteria in the body and normally circulates in the blood (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R22-3&quot;>22<\/a><\/sup>). Inhalation of H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> gas does not influence physiologic parameters such as body temperature, blood pressure, pH, and pO<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> in the blood, as shown previously (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R6-3 R23-3&quot;>6, 23<\/a><\/sup>). Therefore, it is physiologically safe for humans to inhale hydrogen. Hydrogen is a highly diffusible gas and it reacts with hydroxyl radical to produce water (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R24-3&quot;>24<\/a><\/sup>). Dissolving H<sub xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>2<\/sub> in solvent such as physiologic saline, pure water, or medium is easy to apply and is safe. Therefore, it may have great potential for clinical use.<\/p>\n<p id=&quot;O9-3-5&quot;>From the results obtained, we conclude that the ability of reducing the levels of cytokines, such as TNF-\u03b1, IL-2, and the ability of reducing radical oxygen species play important roles in the therapeutic effects of hydrogen. However, the exact mechanism and the signaling pathway involved in the therapeutic role of hydrogen in GVHD need to be studied in the future.<\/p>\n<h2 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;1&quot; id=&quot;HA1-3&quot;>MATERIALS AND METHODS<\/h2>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O10-3&quot;>Hydrogen-Rich Saline Production<\/h3>\n<p id=&quot;O10-3-2&quot;>As we reported previously (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R7-3 R8-3 R10-3&quot;>7, 8, 10<\/a><\/sup>), hydrogen was dissolved in physiologic saline 6 hr under high pressure (0.4 MPa) to a supersaturated level using hydrogen-rich water-producing apparatus produced by our department. The saturated hydrogen saline was stored under atmospheric pressure at 4\u00b0C in an aluminum bag with no dead volume. Hydrogen-rich saline was freshly prepared every week, which ensured that a concentration of more than 0.6 mM was maintained. Gas chromatography (Biogas Analyzer Systems-1000, Mitleben, Japan) was used to confirm the content of hydrogen in saline by the method described by Ohsawa et al. (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R6-3&quot;>6<\/a><\/sup>).<\/p>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O11-3&quot;>Mice<\/h3>\n<p id=&quot;O11-3-2&quot;>All protocols were approved by the Naval General Hospital (Beijing, China) in accordance with the Guide for Care and Use of Laboratory Animals published by the U.S. National Institutes of Health (Publication No. 96-01). Male and female C57BL\/6 (C57) (H-2b) and (BALB\/c\u00d7C57BL\/6) F1 (F1) (H-2d\/b) mice, 8 weeks old, were kept in top-filtered cages in a standard animal facility. Cages, sawdust, and water bottles were autoclaved once a week.<\/p>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O12-3&quot;>Graft-Versus-Host Disease Model<\/h3>\n<p id=&quot;O12-3-2&quot;>The GVHD model was established by the method described previously (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R16-3&quot;>16<\/a><\/sup>). In brief, F1 mice were exposed to 750 cGy total body irradiation at a dose rate of 170 cGy\/min. Spleen cells from donor mice were suspended in PRMI 1640 medium supplemented with 10% fetal calf serum, glutamine (2 mM), penicillin (100 U\/mL), and streptomycin (100 \u03bcg\/mL; Invitrogen, Carlsbad, CA), washed twice, and resuspended in the same medium. One day after irradiation, F1 mice were infused with 20\u00d710<sup xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>6<\/sup> C57BL\/6 spleen cells. As described previously, chimerism was documented by determining the percentage of host- or donor-type cells in blood samples of the transplanted mice (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R25-3&quot;>25<\/a><\/sup>). As we reported previously (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R7-3&quot;>7<\/a><\/sup>), mice were treated intraperitoneally with physiologic saline or hydrogen-rich saline (5 mL\/kg) 24 hr after transplantation every day.<\/p>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O13-3&quot;>Survival Assays<\/h3>\n<p id=&quot;O13-3-2&quot;>For the evaluation of the therapeutic effect of hydrogen, mice were returned to the animal facility and routinely cared for 30 days after BMT. Survival was checked and scored daily for 30 days.<\/p>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O14-3&quot;>Analysis of Cytokine Secretion<\/h3>\n<p id=&quot;O14-3-2&quot;>Mice in all groups were bled on day 7 after BMT and analyzed for the specified cytokines (IL-2, IL-10, and TNF-\u03b1). IL-2, IL-10, and TNF-\u03b1 were measured with a commercial enzyme-linked immunosorbent assay kit (Biosource, Camarillo, CA) according to the instructions of the manufacturer.<\/p>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O15-3&quot;>Clinic Score<\/h3>\n<p id=&quot;O15-3-2&quot;>As described previously (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R26-3 R27-3&quot;>26, 27<\/a><\/sup>), mice were monitored for weight loss, posture, activity, fur change, and skin integrity. The clinical signs of GVHD on the 15th day after BMT were scored on the following criteria provided in <a href=&quot;javascript:void(0)&quot; onclick=&quot;javascript:showSlideShowByImageID('T1-3', '00007890-201303150-00003');&quot;>Table 1<\/a>.<\/p>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O16-3&quot;>Leukocyte Counts<\/h3>\n<p id=&quot;O16-3-2&quot;>For the evaluation of the therapeutic effect of hydrogen, peripheral blood samples were obtained from the tail vein of mice on different days after BMT. The numbers of peripheral blood leukocytes were determined with a hemocytometer as we have described previously (<sup><a class=&quot;ejp-citation-link js-ejp-citation-link&quot; data-reference-links=&quot;R10-3&quot;>10<\/a><\/sup>).<\/p>\n<h3 class=&quot;ejp-article-outline-heading&quot; data-level=&quot;2&quot; id=&quot;O17-3&quot;>Statistical Analysis<\/h3>\n<p id=&quot;O17-3-2&quot;>Survival curves were constructed using the Kaplan-Meier product limit estimator and compared using the log-rank rest. Other results are expressed as mean\u00b1SD and compared by the two-sample Student\u2019s <em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>t<\/em> test for differences in means. <em xmlns_mrws=&quot;http:\/\/webservices.ovid.com\/mrws\/1.0&quot;>P<\/em>&lt;0.05 was deemed to be significant in all experiments.<\/p>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Administration of Hydrogen-Rich Saline Protects Mice From Lethal Acute Graft-Versus-Host Disease (aGVHD)<\/p>\n","protected":false},"author":1,"featured_media":17899,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[130],"tags":[],"disease":[844],"body-organ":[1037],"applications":[682],"test_subjects":[1518],"report-topic":[1344],"class_list":["post-27573","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hydrogen-health","disease-surgery-transplantation-2","body-organ-bone-marrow-2","applications-injection-2","test_subjects-mouse-2","report-topic-graft-versus-hose-disease-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hydrogen-Rich Saline Shields Mice from aGVHD<\/title>\n<meta name=\"description\" content=\"Administration of Hydrogen-Rich Saline Protects Mice From Lethal Acute Graft-Versus-Host Disease (aGVHD)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hydrogen-Rich Saline Shields Mice from aGVHD\" \/>\n<meta property=\"og:description\" content=\"Administration of Hydrogen-Rich Saline Protects Mice From Lethal Acute Graft-Versus-Host Disease (aGVHD)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/\" \/>\n<meta property=\"og:site_name\" content=\"HHO Bulgaria\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/HHOBulgaria\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-03T19:48:44+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-04T19:12:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/hho-bulgaria.com\/wp-content\/uploads\/2023\/12\/Vodorodana-Terapia-ReportsThumb.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1100\" \/>\n\t<meta property=\"og:image:height\" content=\"592\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/\"},\"author\":{\"name\":\"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432\",\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/#\\\/schema\\\/person\\\/11fc655e42cfb1690bfccd38dc15be88\"},\"headline\":\"Hydrogen-Rich Saline Shields Mice from aGVHD\",\"datePublished\":\"2024-01-03T19:48:44+00:00\",\"dateModified\":\"2024-02-04T19:12:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/\"},\"wordCount\":1724,\"publisher\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hho-bulgaria.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Vodorodana-Terapia-ReportsThumb.jpg\",\"articleSection\":[\"Hydrogen Health\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/\",\"url\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/\",\"name\":\"Hydrogen-Rich Saline Shields Mice from aGVHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hho-bulgaria.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Vodorodana-Terapia-ReportsThumb.jpg\",\"datePublished\":\"2024-01-03T19:48:44+00:00\",\"dateModified\":\"2024-02-04T19:12:19+00:00\",\"description\":\"Administration of Hydrogen-Rich Saline Protects Mice From Lethal Acute Graft-Versus-Host Disease (aGVHD)\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hho-bulgaria.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Vodorodana-Terapia-ReportsThumb.jpg\",\"contentUrl\":\"https:\\\/\\\/hho-bulgaria.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Vodorodana-Terapia-ReportsThumb.jpg\",\"width\":1100,\"height\":592},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/hydrogen-rich-saline-shields-mice-from-agvhd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u041d\u0430\u0447\u0430\u043b\u043e\",\"item\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hydrogen-Rich Saline Shields Mice from aGVHD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/\",\"name\":\"HHO Bulgaria\",\"description\":\"\u0413\u0435\u043d\u0435\u0440\u0430\u0442\u043e\u0440 \u043d\u0430 \u0413\u0430\u0437 \u043d\u0430 \u0411\u0440\u0430\u0443\u043d \u0437\u0430 \u0434\u0438\u0437\u0435\u043b\u043e\u0432\u0438 \u0438 \u0431\u0435\u043d\u0437\u0438\u043d\u043e\u0432\u0438 \u0434\u0432\u0438\u0433\u0430\u0442\u0435\u043b\u0438 (\u0432\u043a\u043b\u044e\u0447\u0438\u0442\u0435\u043b\u043d\u043e \u0433\u0430\u0437 \u043f\u0440\u043e\u043f\u0430\u043d-\u0431\u0443\u0442\u0430\u043d \u0438 \u043c\u0435\u0442\u0430\u043d) \u00bb \u0412\u043e\u0434\u043e\u0440\u043e\u0434\u0435\u043d \u0433\u0435\u043d\u0435\u0440\u0430\u0442\u043e\u0440  \u043d\u0430 \u0413\u0430\u0437 \u043d\u0430 \u0411\u0440\u0430\u0443\u043d | HHO \u0433\u0435\u043d\u0435\u0440\u0430\u0442\u043e\u0440, \u043f\u0440\u043e\u0438\u0437\u0432\u0435\u0434\u0435\u043d \u0432 \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f\",\"publisher\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/#organization\",\"name\":\"HHO Bulgaria\",\"url\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/hho-bulgaria.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/HHOBG-FB-Profile-2.png\",\"contentUrl\":\"https:\\\/\\\/hho-bulgaria.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/HHOBG-FB-Profile-2.png\",\"width\":1080,\"height\":1080,\"caption\":\"HHO Bulgaria\"},\"image\":{\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/HHOBulgaria\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UC9d5geU7TFrhO2e7MR6IelA\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hho-bulgaria.com\\\/en\\\/#\\\/schema\\\/person\\\/11fc655e42cfb1690bfccd38dc15be88\",\"name\":\"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4995e9b05624f69b6d4e5e58936980feceb66c508ee1e767d105fa5d9ac07802?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4995e9b05624f69b6d4e5e58936980feceb66c508ee1e767d105fa5d9ac07802?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/4995e9b05624f69b6d4e5e58936980feceb66c508ee1e767d105fa5d9ac07802?s=96&d=mm&r=g\",\"caption\":\"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432\"},\"sameAs\":[\"https:\\\/\\\/hho-bulgaria.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hydrogen-Rich Saline Shields Mice from aGVHD","description":"Administration of Hydrogen-Rich Saline Protects Mice From Lethal Acute Graft-Versus-Host Disease (aGVHD)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/","og_locale":"en_US","og_type":"article","og_title":"Hydrogen-Rich Saline Shields Mice from aGVHD","og_description":"Administration of Hydrogen-Rich Saline Protects Mice From Lethal Acute Graft-Versus-Host Disease (aGVHD)","og_url":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/","og_site_name":"HHO Bulgaria","article_publisher":"https:\/\/www.facebook.com\/HHOBulgaria\/","article_published_time":"2024-01-03T19:48:44+00:00","article_modified_time":"2024-02-04T19:12:19+00:00","og_image":[{"width":1100,"height":592,"url":"https:\/\/hho-bulgaria.com\/wp-content\/uploads\/2023\/12\/Vodorodana-Terapia-ReportsThumb.jpg","type":"image\/jpeg"}],"author":"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432","twitter_card":"summary_large_image","twitter_misc":{"Written by":"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/#article","isPartOf":{"@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/"},"author":{"name":"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432","@id":"https:\/\/hho-bulgaria.com\/en\/#\/schema\/person\/11fc655e42cfb1690bfccd38dc15be88"},"headline":"Hydrogen-Rich Saline Shields Mice from aGVHD","datePublished":"2024-01-03T19:48:44+00:00","dateModified":"2024-02-04T19:12:19+00:00","mainEntityOfPage":{"@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/"},"wordCount":1724,"publisher":{"@id":"https:\/\/hho-bulgaria.com\/en\/#organization"},"image":{"@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/#primaryimage"},"thumbnailUrl":"https:\/\/hho-bulgaria.com\/wp-content\/uploads\/2023\/12\/Vodorodana-Terapia-ReportsThumb.jpg","articleSection":["Hydrogen Health"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/","url":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/","name":"Hydrogen-Rich Saline Shields Mice from aGVHD","isPartOf":{"@id":"https:\/\/hho-bulgaria.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/#primaryimage"},"image":{"@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/#primaryimage"},"thumbnailUrl":"https:\/\/hho-bulgaria.com\/wp-content\/uploads\/2023\/12\/Vodorodana-Terapia-ReportsThumb.jpg","datePublished":"2024-01-03T19:48:44+00:00","dateModified":"2024-02-04T19:12:19+00:00","description":"Administration of Hydrogen-Rich Saline Protects Mice From Lethal Acute Graft-Versus-Host Disease (aGVHD)","breadcrumb":{"@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/#primaryimage","url":"https:\/\/hho-bulgaria.com\/wp-content\/uploads\/2023\/12\/Vodorodana-Terapia-ReportsThumb.jpg","contentUrl":"https:\/\/hho-bulgaria.com\/wp-content\/uploads\/2023\/12\/Vodorodana-Terapia-ReportsThumb.jpg","width":1100,"height":592},{"@type":"BreadcrumbList","@id":"https:\/\/hho-bulgaria.com\/en\/hydrogen-rich-saline-shields-mice-from-agvhd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u041d\u0430\u0447\u0430\u043b\u043e","item":"https:\/\/hho-bulgaria.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hydrogen-Rich Saline Shields Mice from aGVHD"}]},{"@type":"WebSite","@id":"https:\/\/hho-bulgaria.com\/en\/#website","url":"https:\/\/hho-bulgaria.com\/en\/","name":"HHO Bulgaria","description":"\u0413\u0435\u043d\u0435\u0440\u0430\u0442\u043e\u0440 \u043d\u0430 \u0413\u0430\u0437 \u043d\u0430 \u0411\u0440\u0430\u0443\u043d \u0437\u0430 \u0434\u0438\u0437\u0435\u043b\u043e\u0432\u0438 \u0438 \u0431\u0435\u043d\u0437\u0438\u043d\u043e\u0432\u0438 \u0434\u0432\u0438\u0433\u0430\u0442\u0435\u043b\u0438 (\u0432\u043a\u043b\u044e\u0447\u0438\u0442\u0435\u043b\u043d\u043e \u0433\u0430\u0437 \u043f\u0440\u043e\u043f\u0430\u043d-\u0431\u0443\u0442\u0430\u043d \u0438 \u043c\u0435\u0442\u0430\u043d) \u00bb \u0412\u043e\u0434\u043e\u0440\u043e\u0434\u0435\u043d \u0433\u0435\u043d\u0435\u0440\u0430\u0442\u043e\u0440  \u043d\u0430 \u0413\u0430\u0437 \u043d\u0430 \u0411\u0440\u0430\u0443\u043d | HHO \u0433\u0435\u043d\u0435\u0440\u0430\u0442\u043e\u0440, \u043f\u0440\u043e\u0438\u0437\u0432\u0435\u0434\u0435\u043d \u0432 \u0411\u044a\u043b\u0433\u0430\u0440\u0438\u044f","publisher":{"@id":"https:\/\/hho-bulgaria.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hho-bulgaria.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/hho-bulgaria.com\/en\/#organization","name":"HHO Bulgaria","url":"https:\/\/hho-bulgaria.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/hho-bulgaria.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/hho-bulgaria.com\/wp-content\/uploads\/2022\/02\/HHOBG-FB-Profile-2.png","contentUrl":"https:\/\/hho-bulgaria.com\/wp-content\/uploads\/2022\/02\/HHOBG-FB-Profile-2.png","width":1080,"height":1080,"caption":"HHO Bulgaria"},"image":{"@id":"https:\/\/hho-bulgaria.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/HHOBulgaria\/","https:\/\/www.youtube.com\/channel\/UC9d5geU7TFrhO2e7MR6IelA"]},{"@type":"Person","@id":"https:\/\/hho-bulgaria.com\/en\/#\/schema\/person\/11fc655e42cfb1690bfccd38dc15be88","name":"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/4995e9b05624f69b6d4e5e58936980feceb66c508ee1e767d105fa5d9ac07802?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/4995e9b05624f69b6d4e5e58936980feceb66c508ee1e767d105fa5d9ac07802?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4995e9b05624f69b6d4e5e58936980feceb66c508ee1e767d105fa5d9ac07802?s=96&d=mm&r=g","caption":"\u0418\u0432\u0430\u0439\u043b\u043e \u041c\u043b\u0430\u0434\u0435\u043d\u043e\u0432"},"sameAs":["https:\/\/hho-bulgaria.com"]}]}},"_links":{"self":[{"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/posts\/27573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/comments?post=27573"}],"version-history":[{"count":0,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/posts\/27573\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/media\/17899"}],"wp:attachment":[{"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/media?parent=27573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/categories?post=27573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/tags?post=27573"},{"taxonomy":"disease","embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/disease?post=27573"},{"taxonomy":"body-organ","embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/body-organ?post=27573"},{"taxonomy":"applications","embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/applications?post=27573"},{"taxonomy":"test_subjects","embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/test_subjects?post=27573"},{"taxonomy":"report-topic","embeddable":true,"href":"https:\/\/hho-bulgaria.com\/en\/wp-json\/wp\/v2\/report-topic?post=27573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}